$3.00
-0.03-0.99%
Last update: Nov 3, 4:04 PM
DarioHealth Corp
DRIONASDAQ
DarioHealth (DRIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
DarioHealth (DRIO) last issued guidance on July 24, 2023 for Q2 2023. The company guided revenue in the range of $6M - $6.15M for the period.
Compared to prior guidance, DarioHealth lowered its revenue forecast from a prior range of $27.5M - $27.5M.
DarioHealth has issued 3 guidance updates between February 6, 2023 and July 24, 2023. During this period, the company raised its outlook 1 time and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.84 | $-0.90 | $-1.67 | $-3.03 |
| Actual | $-0.72 | $-0.95 | $-0.82 | $-1.91 |
| Surprise | +14.3% | -5.56% | +51.1% | +37.0% |
| Revenue | ||||
| Estimate | $5.8M | $5.5M | $5.1M | $5.7M |
| Actual | $5.2M | $5.6M | $5.2M | $5.0M |
| Surprise | -10.2% | +1.92% | +2.42% | -12.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.54 | $-0.45 |
| Revenue | ||
| Consensus | $5.2M | $5.6M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.72 | $-0.84 | 14.3 % |
| Q1 | May 13, 2026 | $-0.95 | $-0.90 | -5.56 % |
| Q4 | Mar 19, 2026 | $-0.82 | $-1.67 | 51.1 % |
| Q3 | Nov 13, 2025 | $-1.91 | $-3.03 | 37.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $5.18M | $5.76M | -10.2 % |
| Q1 | May 13, 2026 | $5.58M | $5.48M | 1.92 % |
| Q4 | Mar 19, 2026 | $5.20M | $5.08M | 2.42 % |
| Q3 | Nov 13, 2025 | $5.01M | $5.69M | -12.0 % |
